BioClinica Signs Enterprise Agreement for Electronic Data Capture

BioClinica today announced that it has signed a three-year, multi-million dollar agreement for enterprise-wide EDC technology and data management services with a global, multibillion dollar division of a Top 10 pharmaceutical company. Designed for maximum efficiency and flexibility, BioClinica Express will support nearly 200 studies annually for this organization. Together the firms have developed a common data model based on CDISC standards that will facilitate rapid deployment and study closeout while supporting a challenging clinical environment.

The client chose BioClinica Express as part of a broad evaluation of all the leading solutions to achieve its goal of running paperless clinic studies. This agreement marks the second enterprise-level, fullservice EDC agreement that BioClinica has announced this year. BioClinica announced a similar agreement for BioClinica Express and data management services with Cephalon in February.